Selecting The Best Biotech Penny Stocks
Even as many big names in biotech perform well, the author of today’s article notes that “penny biotech stocks, mostly small firms working on only… Read More »Selecting The Best Biotech Penny Stocks
Investor
Should Investors “Say Yes To Drugs” On Heels Of Biogen Approval?
The FDA’s approval of Biogen’s Alzheimer’s drug Aduhelm resulted in shares of the biotech rocketing higher – and the rest of the biotech sector went… Read More »Should Investors “Say Yes To Drugs” On Heels Of Biogen Approval?
Reading The Tea Leaves On Some Major Biotech Catalysts This Month
This month in biotech, “Some of the industry’s biggest players are waiting for clinical trial results and decisions from the FDA that could send their… Read More »Reading The Tea Leaves On Some Major Biotech Catalysts This Month
These 3 Pharmaceutical Stocks Look Significantly Undervalued
After being the target of much investor attention amid the COVID-19 pandemic, many investors have rotated out of the pricey pharmaceutical sector over the past… Read More »These 3 Pharmaceutical Stocks Look Significantly Undervalued
Why Biotech M&A Activity Could Heat Up In June – And Some Potential Acquisition Targets
Due in part to the American Society of Clinical Oncology’s big cancer conference, June is often a popular month for M&A activity in the biotech… Read More »Why Biotech M&A Activity Could Heat Up In June – And Some Potential Acquisition Targets
Bought Out Or Standalone, These 4 Potential Biotech Takeover Targets Are Attractive Picks
After a down year for M&A activity in the biotech industry, 2021 is expected to see greater deal volume – and the four biotechs highlighted… Read More »Bought Out Or Standalone, These 4 Potential Biotech Takeover Targets Are Attractive Picks
Avoid Biotech Regrets By Avoiding These 3 Common Mistakes
When it comes to biotech stocks, the author of today’s article notes that “one of the best — and worst — things about these stocks… Read More »Avoid Biotech Regrets By Avoiding These 3 Common Mistakes
2 Recent Biotech IPOs That Could Be Worth A Speculative Buy
A company using artificial intelligence in the drug discovery and validation process and a company developing long-lasting “irreversible” drugs for the treatment of certain cancers… Read More »2 Recent Biotech IPOs That Could Be Worth A Speculative Buy
Who’s The MVP In mRNA?
Messenger RNA (mRNA) has come to the forefront thanks to its role in the Pfizer-BioNTech and Moderna COVID-19 vaccines – and the potential for the… Read More »Who’s The MVP In mRNA?
Biotech Stocks To Watch As An Effective Alzheimer’s Treatment Remains Elusive
“Alzheimer’s is the holy grail right now in neurology and diseases of the central nervous system (CNS) because as a form of rapid, non-normal dementia,… Read More »Biotech Stocks To Watch As An Effective Alzheimer’s Treatment Remains Elusive